Page last updated: 2024-08-23

ursodeoxycholic acid and Short Bowel Syndrome

ursodeoxycholic acid has been researched along with Short Bowel Syndrome in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's3 (37.50)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moreno Villares, JM1
Adam, R; Reinshagen, K; Trunk, M; Wessel, LM1
Brodlie, S; Carroll, J; Cowles, RA; Harren, PA; Jan, DM; Lobritto, SJ; Martinez, M; Ventura, KA1
Angelopoulou, K; Flaskos, J; Karkavelas, G; Kouti, V; Papazoglou, L; Rallis, T1
Forget, PP; Heemskerk, J; Heineman, E; Sie, GH; Van den Neucker, AM; van Heurn, LW1
Beau, P; Beauchant, M; Ingrand, P; Labat-Labourdette, J1
Andoh, T; Igarashi, Y; Izumi, U; Ohi, R; Ohkohchi, N1
Gutzler, F; Ring, GH; Sauer, P; Stiehl, A; Zimmermann, R1

Reviews

2 review(s) available for ursodeoxycholic acid and Short Bowel Syndrome

ArticleYear
[Parenteral nutrition-associated liver disease].
    Nutricion hospitalaria, 2008, Volume: 23 Suppl 2

    Topics: Age Factors; Cholagogues and Choleretics; Cholestasis; Enteral Nutrition; Humans; Infant, Newborn; Infant, Premature; Liver Diseases; Parenteral Nutrition; Risk Factors; Short Bowel Syndrome; Time Factors; Ursodeoxycholic Acid

2008
The chronic liver disease in patients with short bowel syndrome: etiology and treatment.
    Minerva pediatrica, 2009, Volume: 61, Issue:3

    Topics: Anti-Bacterial Agents; Child; Cholagogues and Choleretics; Cholestasis; Drug Therapy, Combination; Enteral Nutrition; Evidence-Based Medicine; Humans; Infant, Newborn; Infant, Premature; Intestine, Small; Liver Diseases; Parenteral Nutrition; Parenteral Nutrition, Home; Practice Guidelines as Topic; Prognosis; Risk Factors; Sepsis; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid

2009

Other Studies

6 other study(ies) available for ursodeoxycholic acid and Short Bowel Syndrome

ArticleYear
Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Journal of pediatric surgery, 2010, Volume: 45, Issue:1

    Topics: Bilirubin; Biomarkers; Child; Child, Preschool; Cholestasis, Intrahepatic; Enteral Nutrition; Enterocolitis, Necrotizing; Fat Emulsions, Intravenous; Gastrointestinal Motility; Humans; Infant; Infant, Newborn; Infant, Premature; Intestinal Diseases; Intestinal Obstruction; Intestine, Small; Intestines; Liver Diseases; Organ Transplantation; Parenteral Nutrition; Patient Care Team; Postoperative Complications; Referral and Consultation; Rehabilitation Centers; Short Bowel Syndrome; Treatment Outcome; Ursodeoxycholic Acid

2010
Ursodeoxycholic acid promotes intestinal adaptation in a cat model of short bowel syndrome.
    Fundamental & clinical pharmacology, 2011, Volume: 25, Issue:6

    Topics: Adaptation, Physiological; Animals; Cats; Cholagogues and Choleretics; Diarrhea; Disease Models, Animal; DNA; Hyperplasia; Ileum; Intestinal Mucosa; Jejunum; Short Bowel Syndrome; Sucrase; Ursodeoxycholic Acid

2011
Extreme short bowel syndrome in a full-term neonate--a case report.
    Journal of pediatric surgery, 2003, Volume: 38, Issue:11

    Topics: Anastomosis, Surgical; Breast Feeding; Cholagogues and Choleretics; Cholestasis; Diarrhea, Infantile; Humans; Infant, Newborn; Intestinal Volvulus; Intestines; Liver Function Tests; Male; Necrosis; Parenteral Nutrition; Short Bowel Syndrome; Steatorrhea; Ursodeoxycholic Acid

2003
Is ursodeoxycholic acid an effective therapy for total parenteral nutrition-related liver disease?
    Journal of hepatology, 1994, Volume: 20, Issue:2

    Topics: Adult; Aged; Cholestasis; Female; Humans; Male; Middle Aged; Parenteral Nutrition, Total; Short Bowel Syndrome; Ursodeoxycholic Acid

1994
Disorder of bile acid metabolism in children with short bowel syndrome.
    Journal of gastroenterology, 1997, Volume: 32, Issue:4

    Topics: Adolescent; Bile Acids and Salts; Child; Child, Preschool; Diarrhea; Fats; Feces; Female; Humans; Infant; Male; Short Bowel Syndrome; Ursodeoxycholic Acid

1997
Ursodeoxycholic acid enhances the absorption of cyclosporine in a heart transplant patient with short bowel syndrome.
    Transplantation proceedings, 1992, Volume: 24, Issue:6

    Topics: Administration, Oral; Azathioprine; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Humans; Intestinal Absorption; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Short Bowel Syndrome; Ursodeoxycholic Acid

1992